AgonOx, Inc. develops novel therapies to treat cancer patients. The research strategy at AgonOx focuses on the interaction between T cells and tumor cells. Using bioinformatics, in-vitro, and in-vivo testing to identify and validate new therapeutic approaches. AgonOx conducts its research in laboratories at the Portland Providence Cancer Center where staff scientists work closely with oncologists, surgeons, and immunologists. This collaboration has led to two first-in-human clinical trials with the latest commencing in August 2023. The company’s focus in recent years has been utilizing selected tumor-reactive T cells in adoptive cell therapy for the treatment of patients with solid malignancies.
View Top Employees from AgonOx, Inc.Website | http://agonox.com |
Revenue | $2 million |
Employees | 6 (6 on RocketReach) |
Founded | 2012 |
Address | PO Box 1455, Portland, Oregon 97207, US |
Phone | (503) 796-9343 |
Technologies |
JavaScript,
HTML,
Twitter
+8 more
(view full list)
|
Industry | Biotechnology, Business Services General, Business Services, Science and Engineering, Pharmaceutical, Health Care |
Competitors | Dragonfly Therapeutics, Inc., MORADEC LLC, ProMab Biotechnologies, Inc., Proteos, UbiVac |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies |
Looking for a particular AgonOx, Inc. employee's phone or email?
The AgonOx, Inc. annual revenue was $2 million in 2024.
6 people are employed at AgonOx, Inc..
AgonOx, Inc. is based in Portland, Oregon.
The NAICS codes for AgonOx, Inc. are [54171, 54, 541714, 5417, 541].
The SIC codes for AgonOx, Inc. are [873, 87].